Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement-Reference-Cited by-同舟云学术

Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement

Published:2020-01 Issue: Volume:63 Page:101-105
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Viviani Laura,Halder Marlies,Gruber Marion,Bruckner Lukas,Cussler Klaus,Sanyal Gautam,Srinivas Geetha,Goel Sunil,Kaashoek Marianne,Litthauer Derek,Lopes da Silva Arthur Leonardo,Sakanyan Elena,Aprea Patricia,Jin Hongtao,Vandeputte Joris,Seidle Troy,Yakunin Dimitriy

Funder

Lush Fresh Handmade Cosmetics Inc.

Lush Cosmetics

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference16 articles.

1. Abnormal Toxicity - a study in the relevance of the requirement V.2.1.5 of the Deutsche Arzneibuch (German Pharmacopoeia) for vaccines, immunosera and immunoglobulins;Duchow,1995

2. Ist die tierexperimentelle Prüfung auf anomale Toxizität für Impfstoffe, Sera and Immunglobuline noch zeitgemaess?;Kramer;ALTEX,1996

3. Elimination of abnormal toxicity test for sera and certain vaccines in the European Pharmacopoeia;Schwanig;Vaccine,1997

4. The target animal safety test is it still relevant? Advisory group on alternatives to animal testing in Immunobiologicals;AGAATI;Biologicals,2002

5. Historical data analyses and scientific knowledge suggest complete removal of the abnormal toxicity test as a quality control test;Garbe;J Pharm Sci,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. False positive findings associated with adenoviral vector-based vaccine underscore the regulatory necessity to eliminate abnormal toxicity test;Regulatory Toxicology and Pharmacology;2024-05

2. Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of National Control Laboratories and National Regulatory Authorities;Biologicals;2023-11

3. Aplicação de métodos alternativos ao uso de animais no desenvolvimento e controle da qualidade de produtos imunobiológicos no Brasil;Vigilância Sanitária em Debate;2023-04-19

4. Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals: Responses from a survey of vaccines and biological therapeutics manufacturers;Biologicals;2023-02

5. The role of ‘big data’ and ‘in silico’ New Approach Methodologies (NAMs) in ending animal use – A commentary on progress;Computational Toxicology;2022-08